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Background: Iron homeostasis is chiefly regulated by hepcidin whose expression is tightly controlled by
inflammation, iron stores, and hypoxia. Hemojuvelin (HJV) is a bone morphogenetic protein co-receptor that has
been identified as a main upstream regulator of hepcidin expression; HJV mutations are associated with a severe
form of iron overload (Juvenile haemochromatosis). Currently however, there is no information on how HJV is
regulated by inflammation.
Methods: To study the regulation of Hjv expression by inflammation and whether Hfe has a role in that regulation,
control and LPS-injected wild type and Hfe KO mice were used. Moreover, human hepatoma cells (HuH7) were
used to study the effect of IL-6 and TNF-α on HJV mRNA expression.
Results: Here we show that LPS repressed hepatic Hjv and BMPs, while it induced hepcidin 1 expression in
wild-type and Hfe KO mice with no effect on hepatic pSMAD 1, 5, 8 protein levels. In addition, exogenous TNF-α
(20 ng/mL) decreased HJV mRNA and protein expression to 40% of control with no effect on hepcidin mRNA
expression in 24 hours. On the other hand, IL-6 induced hepcidin mRNA and protein expression with no effect on
HJV mRNA expression levels. Moreover, using the HJV promoter-luciferase reporter fusion construct (HJVP1.2-luc), we
showed that the basal luciferase activity of HJVP1.2-luc was inhibited by 33% following TNF-α treatment of HuH7
transfected cells suggesting that the TNF-α down-regulation is exerted at the transcriptional level. Additionally,
mutation of a canonical TNF- alpha responsive element (TNFRE) within HJVP1.2-luc abolished TNF-α response
suggesting that this TNFRE is functional.
Conclusions: From these results, we conclude that TNF-α suppresses HJV transcription possibly via a novel TNFRE
within the HJV promoter. In addition, the results suggest that the proposed link between inflammation and
BMP-SMAD signalling is independent of HJV and BMP ligands.
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Inflammatory stimuli are associated with profound
alterations in iron homeostasis. Among the most crucial
of these changes are the redistribution of iron into reti-
culoendothelial macrophages, and reduced intestinal
iron absorption causing hypoferremia [1-4]. Similar find-
ings have also been reported in mice exposed to endo-
toxins [5]. The impairment of iron efflux by enterocytes* Correspondence: mohamed.salama@uclmail.net
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reproduction in any medium, provided the orand reticuloendothelial macrophages is believed to play
an important role in host defence against infection and
cancer by limiting iron availability for pathogen or cancer
cell replication [6,7]. However, one consequence of this
is the anaemia of inflammation [8]. Pro-inflammatory
cytokines have been shown to modulate the expression
of iron transport and storage proteins in a variety of cell
types [9-11]. During inflammation, IL-6 induces hepcidin
expression through phosphorylation of Stat3 that binds
to the Stat3 response element (Stat3RE) within the hepci-
din gene promoter [12-14], increases hepcidin expression
which in turn decreases intestinal iron absorptionLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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study showed that humans injected with bacterial lipo-
polysaccharide (LPS) produced IL-6 within 3 hours, with
concomitant increases in circulating hepcidin, and result-
ing in hypoferremia and reduced serum iron; similar find-
ings were made in humans injected with IL-6 [20,21].
Sterile inflammation induced with turpentine produced
similar responses in mice [22,23]. The finding that hepci-
din is modulated by inflammatory cytokines or LPS has
linked its expression levels to the anaemia of inflamma-
tion, otherwise referred to as the anaemia of chronic
disease [17,24].
Hemojuvelin, a Bone Morphogenetic Protein (BMP)
co-receptor, has been shown to be an important up-
stream regulator of hepcidin expression [25]. In mice
lacking Hjv, hepcidin induction in response to iron is
abrogated. On the other hand, these mice retain the abil-
ity to regulate hepcidin in response to inflammation by
LPS and IL-6, though to a lesser extent than wild-type
animals [26]. Moreover, Hjv expression was down-
regulated in the liver of mice injected with LPS [26].
These findings suggest that Hjv may not be directly
involved in the hepcidin response to inflammatory stim-
uli while it is required for hepcidin response to iron. Re-
cently it has been shown that mice lacking hepatic
Smad-4 express very low hepcidin levels. In addition, the
response of hepcidin to inflammation was abrogated in
these mice [27]. Although the proximity of the Stat3RE
to a BMP-response element (only 6 nucleotides apart)
within the human hepcidin promoter [28] would suggest
some amount of transcriptional cross-talk between the
Stat3/IL-6 [13] and the Smads/BMP signalling pathways
in hepcidin induction; however, this link remains to be
clarified.
Evidence for the requirement of Hfe for hepcidin in-
duction during inflammation is conflicting. A group
reported that mice lacking Hfe do not respond to LPS
with increased hepcidin expression as wild-type animals
[17]. In another study, the LPS response was signifi-
cantly different among animals [29]. A recent study
showed that Hfe knockout (KO) mice were just as able
to regulate hepcidin in response to LPS as wild-type ani-
mals [30]. These contradictory findings on the require-
ment of Hfe for hepcidin induction during acute
inflammation might be partly explained by different con-
centration of LPS used in these studies, but the study of
Hfe KO mice during the inflammatory response requires
further investigation. Moreover, the mechanism of regu-
lation of HJV during inflammation is not clearly under-
stood and needs further investigations. Therefore, this
study aimed to understand the mechanism of HJV regu-
lation during inflammation, to investigate the interplay
between Hfe and the Smad/BMP pathway in regulating
hepcidin expression, and to better understand howimportant this might be for the changes in iron flux that
occur during inflammation.
Methods
Induction of acute inflammation in mice
Wild-type C57Bl/6 (n = 10) and Hfe KO (of C57Bl/6
background strain; n = 10) female mice were supplied by
the Comparative Biology Unit at the Royal Free and
UCL Medical School, London. All the experimental pro-
cedures were conducted in agreement with the UK ani-
mals (Scientific Procedures) Act, 1986. Animals were
kept in a 12 hour light–dark cycle, provided with water
ad libitum, and were fed control diet (RM1 diet; 190 mg
Fe/kg diet) for six weeks after being weaned (3 weeks of
age). Acute inflammation was induced by a single intra-
peritoneal injection of 5 μg LPS/g body weight (Escheri-
chia coli serotype 055:B5, Sigma, UK). Control mice
were similarly injected with an equivalent volume of
sterile saline solution (0.09% NaCl). The mice were ter-
minally anaesthetised with intraperitoneal pentobarbit-
one sodium (Sagatal, Rhone-Merieux, UK, 90 mg/Kg) 6
hours after injection, the time at which maximal hepci-
din induction and Hjv repression have been reported
[26,31,32]. Livers were snap-frozen in liquid N2, and
stored at −80°C for real-time PCR analysis, liver iron
quantification, and immunoblotting.
Cell culture and treatment with cytokines
HuH7 hepatoma cells were obtained from the UCL Insti-
tute of Hepatology. The cells were cultured in Dulbecco’s
Minimal Essential Medium (DMEM; Invitrogen) and
supplemented with non-essential amino acids, 10% foetal
bovine serum, and antibiotics; cells were grown under
standard cell culture conditions. The cells were seeded in
6-well plates (Nunc, UK). At 80-85% confluence, the
medium was changed and replaced with fresh medium
with vehicle (control) or with medium containing recom-
binant human IL-6 (10 ng/mL; R&D Systems, UK) or re-
combinant human TNF-α (20 ng/mL; R&D Systems).
Both cytokines were reconstituted in sterile PBS contain-
ing 0.1% bovine serum albumin. After treatment,
medium was removed and cells were washed with PBS.
RNA extraction and RT-PCR
RNA was extracted from HuH7 cells and from mouse
livers using TRIzol (Invitrogen) according to the manu-
facturer’s instructions. Total RNA (1 μg) was reverse-
transcribed using the Verso cDNA kit (Thermofisher
Scientific) as instructed by the manufacturer. RT-PCR
was performed using Lightcycler (Roche); human
GAPDH and mouse β-actin were used as internal con-
trols. Duplicate PCR reactions were run for each target
gene including GAPDH or β-actin; each reaction mix
contained 1μL of cDNA template, 5pmol each of
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Tect SYBRW Green PCR master mix and water to a final
volume of 20 μL. As a negative control, samples without
cDNA were included. The primers used for real-time
PCR were synthesised by Sigma-Genosys Ltd. (Poole,
UK) and are shown in (Table 1). Gene expressions were
normalized to that of the GAPDH or β-actin and repre-
sented as ΔCt values. For each sample the mean of the
ΔCt values was calculated.Immunoblotting
To investigate the effect cytokines on HJV or hepcidin
expression, HuH7 cells were either untreated or treated
with TNF-α or IL-6 respectively for 24 hours. Proteins
were extracted with RIPA buffer (Santa Cruz) containing
protease and phosphatase inhibitors (Sigma); protein
content was determined with the Pierce BCA protein
assay system. Approximately 50 μg aliquots of homoge-
nates were diluted with an equal volume of 2× Laemmli
sample buffer, heated at 40°C for 30 min and resolved
on a 12% polyacrylamide gel (Bio-Rad) at 40 mA. Pro-
teins were transferred onto PVDF membranes (Bio-Rad),
using a Bio-Rad Trans-Blot SD semi-dry blotter. After
transfer, the blots were washed in distilled water (3 × 1
min) and incubated in 10% glutaraldehyde overnight.
After washing 3 × 5 min with distilled water, the mem-
brane was incubated with 5% non-fat dry milk in PBS-T
(PBS/0.1% Tween 20) overnight at 4°C, with gentle agita-
tion. A 1:2000 or 1: 1000 dilution of affinity-purified
anti-hepcidin antibody [33] or anti-HJV antibody (Santa
Cruz Biotechnology, UK), respectively was added and
then incubated overnight at 4°C. Membrane blots were
then washed 1 × 15 min and then a further 3 × 5 min
with PBS-T, and primary antibodies were probed with an
HRP-conjugated secondary IgG at a 1:5000 dilution in
PBS-T for 1 hour at room temperature, with continuous












mouse TGF- β CACCGGAGAGCCCTGGA
mouse β-actin GACGGCCAAGTCATCACTAmembrane was washed 3 × 10mins with PBS-T for at
room temperature. Detection was performed with the
ECL detection kit (Amersham Life Science), in a Fluor-S
MultiImager (Bio-Rad). The membrane was also probed
with a 1:20,000 dilution of HRP-conjugated anti-actin
antibody AC-15 (Abcam) to ascertain equivalent sample
loading. Hepatic expression of phosphorylated Smad-1/
5/8 in saline and LPS injected mice was determined by
Western blotting using a 1:500 dilution of a phospho-
Smad antibody (Cell signalling, UK).Generation of HJV promoter-reporter construct
A portion of the human HJV promoter extending
1.2Kb upstream of the beginning of the first HJV exon
was amplified by PCR from placental genomic DNA
using the PTC-100 thermocycler (MJ Research) and
Phusion High- Fidelity DNA Polymerase (New Eng-
land Biolabs, UK). The following primers were used:
sense 50 CATGCTAGCAAGTGACCCTCCTGCCT
CAG, the NheI restriction site is underlined; antisense
50 CATCTCGAGCTGCTGTCTCACTGAGGTCA, the
XhoI restriction site is underlined; both were synthe-
sised by Sigma-Genosys Ltd. The PCR reaction mix
contained 250 ng of human genomic DNA, forward
and reverse primers (final concentration of 0.5 μM),
10μL 5× Phusion HF Buffer, 500 μM each of dNTPs, 1
unit of Phusion DNA polymerase, and water to a final
volume of 50μL. The cycling parameters were 98°C for
10 seconds (denaturation), 72°C for 2 min (annealing
and extension); 35 cycles of PCR were performed with
a final extension for 7 min at 72°C. The PCR products
were digested with NheI-XhoI (New England Biolabs,
UK), purified with Geneclean (BIO101, UK), ligated
into NheI-XhoI-restricted pGL3 Basic vector (Pro-
mega) using the Quick ligation kit (NEB), and trans-
formed into DH5α competent cells (Invitrogen).
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and XhoI to identify recombinants. The promoter
clone generated, HJVP1.2-luc, was sequenced for
verification.
Site-directed mutagenesis of HJVP1.2-luc TNF-α response
element (TNFRE)
A single putative TNFRE, GGC (A/T) GCC, was visually
identified in HJVP1.2-luc. To test whether the identified
TNFRE was functional, HJVP1.2-luc was subjected to site-
directed mutagenesis using the QuikChange Site-Directed
Mutagenesis kit (Stratagene, UK) as instructed by the
manufacturer. The mutant primers were as follows: sense
TGAAAATGCTGGAGGaAttCTTGGAGTAGGCAGTG
and antisense CACTGCCTACTCCAAGaaTtCCTCCAG-
CATTTTCA; mutated nucleotides (lower case) formed an
EcoRI restriction site (underlined) that was used as a mar-
ker for successful mutagenesis of HJVP1.2-luc. After initial
denaturation for 1 minute at 95°C, PCR cycling para-
meters were 95°C (1 minute), 55°C (1 minute), and 65°C
(6 minutes), for a total of 18 cycles. Following DpnI diges-
tion of wild-type HJVP1.2-luc, transformation of INVαF’
competent cells (Invitrogen) with the mutagenesis reac-
tion and selection on LB agar/ampicillin plates, plasmid
DNA was purified from overnight cultures of single col-
onies and digested with EcoRI (New England Biolabs), to
distinguish wild-type from mutant HJVP1.2-luc The mu-
tant construct was sequenced for authenticity and was
designated mtHJVP1.2-luc.
Transfections and reporter assays
HuH7 cells were seeded in 24-well plates (Corning) and
transfected at ~80-90% confluence with 200 ng of either
HJVP1.2-luc or mtHJVP1.2-luc using Lipofectamine
2000 (Invitrogen); reporter assays were measured and
luciferase levels were normalized with respect to β-
galactosidase activity as described previously [34].
Results
Correlative changes in iron regulatory protein expression
during LPS-induced acute inflammation in vivo
Since the premise of our study was to examine how in-
flammation might cause changes in iron flux, we trea-
ted wild-type C57Bl/6 and Hfe KO mice for 6 hours
with LPS to induce an acute inflammatory response.
We first measured liver mRNA levels of IL-6 and TNF-
α in saline- and LPS- injected mice by RT-PCR. As
expected, treatment with LPS significantly increased IL-
6 and TNF-α expression levels in the liver of wild-type
and Hfe KO mice (Figure 1A). Since these cytokines
impact hepcidin and Hjv expression respectively, we
determined their mRNA levels as well as those of hep-
cidin and Hjv in saline- and LPS-injected wild-type andHfe KO mice. Treatment with LPS significantly
increased hepcidin 1 expression but decreased Hjv ex-
pression levels in wild-type and Hfe KO mice; their ex-
pression profiles were similar in both genotypes
(Figure 1B). Moreover, Hfe KO mice showed less hepci-
din 1 expression than wild-type animals although this
was not statistically significant.
To assess if there was a link between this inflamma-
tory response and the BMP-Smad signalling pathway
and whether Hfe might be involved, BMP 2, 4, and 6,
and TGF-β gene expression levels were also analysed.
LPS treatment significantly decreased the mRNA ex-
pression levels of BMP2, BMP4, and BMP6 (Figure 1C)
in wild-type and Hfe KO mice. However, it had no ef-
fect on the expression levels of TGF-β and pSmad 1, 5,
and 8 protein expression levels in either genotypes
(Figure 2A).
Next, we asked whether these changes in iron regula-
tory gene expression affected liver iron levels. Liver iron
content measurement showed that acute inflammation
increased hepatic iron content in wild-type mice though
not significantly, but there was no change in liver iron in
LPS-injected Hfe KO mice which already showed rela-
tively higher liver iron levels compared with both un-
treated or LPS-treated wild-type animals (Figure 2C).
IL-6 induces hepcidin while TNF-α suppresses HJV
expression
To compare the expression profiles of hepcidin and HJV
during the inflammatory response, we treated HuH7 cells
with the pro-inflammatory cytokines, IL-6 and TNF-α for
24 hours. We found that IL-6 induced a significant
increase in hepcidin mRNA (up to 3-fold) but it had no
effect on HJV expression (Figure 3A). On the other hand,
TNF-α significantly decreased HJV mRNA expression
levels in a time-dependent manner but showed no dis-
cernible effect on hepcidin mRNA expression (Figure 3B).
Maximal repression was observed after 24 hours, and HJV
mRNA expression levels returned to normal homeostatic
levels after 48 hours (Figure 3C). Next, we asked if the
changes in hepcidin and HJV mRNA were reflected in
their cognate protein levels. Using immunoblotting, we
indeed found that hepcidin protein levels were induced in
IL-6 treated cells, while HJV protein levels were signifi-
cantly reduced in TNF-α treated cells compared to control
(Figure 4A&B).
TNF-α represses HJV transcription
We identified a single, putative TNF-α response element
(TNFRE) in the HJV promoter, 277 nucleotides
upstream of the transcription start site (Figure 5A).
Similar sequences have been shown to mediate the
down-regulation of several human genes in response to
TNF-α including osteocalcin, thrombomodulin, alkaline
Figure 1 Effect of acute inflammation on hepatic gene expression in wild-type and Hfe KO mice. A) IL-6 and TNF-α mRNA expression
levels were analysed by real time PCR. B) Hepcidin 1 and Hjv mRNA levels were analysed by RT-PCR. C) BMP-2, BMP-4, BMP-6, and TGF-β mRNA
expression were analysed by RT-PCR. Data are mean± SEM (n = 5).*p <0.05, **p <0.01, ***p <0.001 in LPS-injected mice compared to
saline-injected controls.
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mechanism might underlie HJV regulation, we transfected
HuH7 cells with HJVP1.2-luc. Luciferase assays showed
that the basal luciferase activity of HJVP1.2-luc was inhib-
ited by about 40% following TNF-α treatment (Figure 5B),
suggesting that the cloned promoter region was respon-
sive to TNF-α. In order to ascertain whether this site was
functional and responsible for TNF-α suppression of HJVexpression, it was deleted by site-directed mutagenesis to
generate mtHJVP1.2-luc. This approach confirmed that
the TNFRE alone within HJVP1.2-luc was sufficient for
HJV down-regulation by TNF-α because its deletion abol-
ished TNF-α responsiveness whereas the wild-type pro-
moter was repressed by this cytokine (Figure 6). These
data strongly suggest that TNF-α suppresses the transcrip-
tion of HJV through this RE.
Figure 2 Effect of inflammation on Smad1/5/8 phosphorylation and liver iron in wild-type C57BL/6 and Hfe KO mice. (A) Western
blotting of liver lysates from saline- or LPS-injected WT and Hfe KO mice using an antibody to phosphorylated Smad1/5/8; β-actin was used as
loading control. (B) Chemiluminescence was quantified using Quantity One software to calculate the ratio of phosphorylated Smad1/5/8 to
β-actin. Mean ratios of four samples (± SEM) are represented relative to the mean ratio of the saline-injected WT or Hfe KO mice. C) Liver iron was
quantified; iron levels are expressed as μg/g dry weight. Data are mean± SEM (n = 5).* denotes significant difference from LPS-injected WT mice
(p <0.05). ** denotes significant difference from the saline–injected WT mice (p <0.01).
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The thrust of our study was to gain some understanding of
how inflammation might induce changes in the expression
of genes that regulate iron metabolism, and to evaluate and
extrapolate some possible consequences that might have in
human disease. First, we investigated hepcidin1 and Hjv ex-
pression in C57Bl/6 mice during acute inflammation. The
results showed that LPS induced hepcidin 1 expression in
mice in accordance with previous reports [30,39], but
decreased the expression of Hjv, BMP-2, BMP-4, andBMP-6 in the liver. Decreased expression of Hjv by LPS is
in agreement with previous reports [32,40]. Hfe did not ap-
pear to contribute to the regulation of these genes during
inflammation because there were no differences in
hepcidin1 expression between wild-type and knockout
mice; this is consistent with other findings [29,30] but is in
sharp contrast to other reports where inflammation
induced with a lower dose of LPS than the one used in this
study reported blunted expression of hepcidin in Hfe KO
mice [17].
Figure 3 Quantitative RT-PCR analysis of hepcidin and HJV mRNA expression in HuH7 cells following IL-6 and TNF-α treatment. A)
HuH7 cells were incubated for 24 hours in the presence of vehicle (control) or IL-6 (10 ng/mL). B) HuH7 cells were incubated for 24 hours in the
presence of vehicle (control) or TNF-α (20 ng/mL) and quantitative PCR was performed for hepcidin and HJV gene expression. Data are
mean± SEM of 6 samples from 3 separate experiments performed in duplicate. ***p <0.001. (C) HuH7 cells were incubated in the presence of
vehicle (control) or TNF-α (20 ng/mL) for 6, 12, 24, and 48 hours. Quantitative PCR for HJV mRNA expression was performed for 6 samples, each
run in triplicates, in 2 separate experiments. Data are mean± SEM . *p <0.05, ***p <0.001.
Salama et al. Journal of Biomedical Science 2012, 19:83 Page 7 of 12
http://www.jbiomedsci.com/content/19/1/83The direct regulation of hepcidin and HJV expression
by pro-inflammatory cytokines was also examined
in vitro using a human hepatoma cell line (HuH7).
These cells were also used to study the mechanism of
HJV regulation during inflammation using a HJV
promoter-reporter construct. We found that TNF-α, but
not IL-6, mediated HJV down-regulation during inflam-
mation, whereas IL-6 was required to induce hepcidin
expression in HuH7 cells. Hepatic Hjv expression wasalso down-regulated by LPS in wild-type and Hfe KO
mice, consistent with other reports [40]. These data
imply that the ability to down-regulate Hjv expression
during the acute phase response remains intact even in
the absence of functional Hfe. Our results also showed
that TNF-α-induced HJV suppression was mediated by a
TNF-α response element within the HJV promoter.
It is well established that BMPs induce hepcidin expres-
sion through Smad signalling via a common mediator,
AHJV
KDaB 1 2 3 4
Hepcidin 10
β-actin
Figure 4 Western blot analysis of hepcidin and HJV protein expression in HuH7 cells following IL-6 and TNF-α treatment. A) Cell lysates
from control (lanes 1-3) and TNF-α treated (lanes 4-6) cells were analyzed by Western blotting with an antibody to HJV; β-actin was used as
loading control. A representative experiment is shown. (B) Cell lysates from control (lanes 1, 3) and IL-6 treated (lanes 2, 4) cells were analyzed by
Western blotting with an antibody to hepcidin; β-actin was used as loading control. A representative experiment is shown. Protein molecular
weight markers are in kDa.
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of Smad-4 in the liver, the response of hepcidin to inflam-
matory stimulation was blunted [41]. Moreover, a recently
identified BMP-responsive element within the hepcidin
gene promoter was found to be not only important for the
BMP response but also for IL-6 responsiveness [28]. These
data suggest that there might be cross-talk between the
IL-6 and the BMP-Smad signalling pathways. We there-
fore investigated the possible interaction between inflam-
mation and BMP/Smad signalling in LPS-induced acute
inflammation in wild-type and Hfe KO mice. Because
BMPs transmit signals through phosphorylation of Smad1,
Smad5 and Smad8, the relative abundance of the phos-
phorylated forms of these three Smads was also quantified
in liver extracts of LPS- and saline- injected wild-type and
Hfe KO mice by Western blot analysis. Interestingly, we
found that BMP-2, BMP-4, and BMP-6 mRNA expression
levels were down-regulated during acute inflammation in
wild-type and Hfe KO mice but there was no change in
phosphorylated Smad1/5/8 expression in the liver. Inaddition, no change was observed in TGF-β expression in
response to inflammation that could maintain the basal
expression levels of phosphorylated Smads [42]. These
findings suggest that BMPs are not required for hepcidin
induction during inflammation; we propose that if there is
any link between inflammation and Smad signalling, it
probably lies downstream of BMP ligands, and is probably
Hfe-independent. To our knowledge, this is the first dem-
onstration that BMP expression may be influenced by in-
flammation in vivo; however, the exact mechanism and its
implication need further investigation.
LPS is recognized by Toll-like receptor (TLR) 4 which,
upon activation, produces pro-inflammatory cytokines
such as TNF-α, IL-1, and IL-6 through NFκB [43,44].
Given this information, it is unclear why the same ligand
(LPS) or signalling pathway produces cytokines that have
variable effects on hepcidin expression, i.e. that IL-6, but
not TNF-α, induces hepcidin during inflammation. Our
observation that TNF-α repressed HJV in liver cells
strongly suggests that these cytokines impact hepcidin and
Figure 5 Genomic context of the TNFRE in the HJV promoter; and luciferase reporter activity of HJVP1.2-luc transfected HuH7 cells
following TNF-α treatment. A) The consensus TNF-α RE (underlined) lies 277 nucleotides upstream of the transcription start site (bold italic).
(B) HuH7 cells were transfected with HJVP1.2-luc and incubated for 24 hours with TNF-α (20 ng/ml). Luciferase expression in both treated and
untreated cells were normalized to β-galactosidase expression. Data are mean± SEM, n = 12 from 3 separate experiments; **p <0.0001.
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mediated down-regulation of HJV expression is not only
in accord with other previous findings [40] but also
extends them with (our) new data which show that TNF-α
uniquely drives HJV repression through a response elem-
ent in the promoter of this gene. Mutational analysis con-
firmed that this element was indeed necessary and
sufficient for TNF-α responsiveness. An addedFigure 6 Luciferase reporter activity of HJVP1.2-luc and mtHJVP1.2-luc
were transfected with HJVP1.2-luc or mtHJVP1.2-luc to verify that the identif
hours in the presence of TNF-α (20 ng/ml). Data are mean± SEM, n = 12 ofcomplication is the role of the BMPs in modulating hepci-
din expression through HJV and at present it is unclear
how the interplay between TNF-α on one hand and the
BMPs on the other, affects hepcidin expression through
HJV. However, this conundrum appears to have been
resolved by recent findings that mice lacking either Hjv or
Bmp-6 retained the ability to induce hepcidin in response
to inflammatory stimuli [26,45]; this indicates that neithertransfected HuH7 cells following TNF-α treatment. HuH7 cells
ied TNFRE is functional. Transfected HuH7 cells were incubated for 24
3 independent experiments. ***p <0.0001.
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flammation. However, both Hjv and BMP-6 have been
shown to be required for iron sensing by hepcidin.
On the basis of our observations we propose a mechan-
ism (Figure 7) in which iron flux through HJV-BMP-
Smad signalling is curtailed by LPS-induced TNF-α. The
fundamental reason (see below) for such a control is not
only interesting in itself but also because TNF-α is a first-
responder, its expression is transient (being maximal at
about 2 hours after LPS treatment), and returning to
basal levels by 6 hours [46]; the latter time-point coin-
cides with maximal acute phase response by the liver
when hepcidin is most expressed. Since soluble HJV is a
potent repressor of hepcidin expression [41], it would
therefore appear that TNF-α constrains HJV expression
in order to enable subsequent hepcidin induction in the
acute phase response through IL-6/Stat3 signalling. InFigure 7 Proposed mechanism of the inter-relationship between hepc
the effect on iron flux. LPS is taken up by Kupffer cells via TLR-4 and indu
within the HJV promoter, while IL-6 induces hepcidin expression via the STA
via an as yet unknown mechanism. Thus, iron sensing by the BMPs, HJV an
inflammatory signalling by IL-6 through hepcidin remains intact.other words, TNF-α simply serves as an initiator and to
prime hepcidin expression in the acute phase response
through IL1β and IL-6 which are integral to that process.
Our model is supported by recent observations that mice
lacking Bmp-6 [47] which signals through Hjv, still
retained the ability to express hepcidin in response to
LPS precisely because the early response phase had been
by-passed or because the BMP-6 and IL-6 pathways are
separable but convergent, i.e. there may be cross-talk be-
tween these two disparate pathways [28]. Taken together
with other findings, our results may improve our under-
standing of how this cross-talk (or lack of it) may deter-
mine how hepcidin expression is regulated by infection/
inflammation [48]. However, how that may determine the
development and course of the anaemia that results, and
the search for small-molecule antagonists that target this
pathway needs further investigation.idin and HJV expression during the inflammatory response, and
ces TNF-α, IL-1, and IL-6. TNF-α suppresses HJV expression via a TNFRE
T3 pathway. LPS also represses the expression of BMPs (2, 4, and 6),
d BMP receptor involved in regulating hepcidin is abrogated whereas
Salama et al. Journal of Biomedical Science 2012, 19:83 Page 11 of 12
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Our results demonstrate that TNF-α suppresses HJV
transcription via a novel TNFRE within its promoter.
We propose that the link between inflammation and
BMP-SMAD signalling is downstream of HJV and BMP
ligands; this link and its implication need further studies.
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